131 related articles for article (PubMed ID: 18583174)
21. A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
Sass MB; Lorenz AN; Green RL; Coleman RA
J Neurosci Methods; 2009 Apr; 178(2):366-77. PubMed ID: 19136028
[TBL] [Abstract][Full Text] [Related]
22. Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein.
Bandyopadhyay U; Cuervo AM
Exp Gerontol; 2007; 42(1-2):120-8. PubMed ID: 16860504
[TBL] [Abstract][Full Text] [Related]
23. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
Chang C; Lang H; Geng N; Wang J; Li N; Wang X
Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
[TBL] [Abstract][Full Text] [Related]
24. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
Koo HJ; Choi MY; Im H
Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
[TBL] [Abstract][Full Text] [Related]
25. Controlling the mass action of alpha-synuclein in Parkinson's disease.
Kim C; Lee SJ
J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
[TBL] [Abstract][Full Text] [Related]
26. MPP+ impairs autophagic clearance of alpha-synuclein by impairing the activity of dynein.
Cai ZL; Shi JJ; Yang YP; Cao BY; Wang F; Huang JZ; Yang F; Zhang P; Liu CF
Neuroreport; 2009 Apr; 20(6):569-73. PubMed ID: 19287320
[TBL] [Abstract][Full Text] [Related]
27. Review: autophagy in neurodegeneration: firefighter and/or incendiarist?
Rami A
Neuropathol Appl Neurobiol; 2009 Oct; 35(5):449-61. PubMed ID: 19555462
[TBL] [Abstract][Full Text] [Related]
28. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
[TBL] [Abstract][Full Text] [Related]
29. Neuronal macroautophagy: from development to degeneration.
Boland B; Nixon RA
Mol Aspects Med; 2006; 27(5-6):503-19. PubMed ID: 16999991
[TBL] [Abstract][Full Text] [Related]
30. Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
Kazantsev AG; Kolchinsky AM
Arch Neurol; 2008 Dec; 65(12):1577-81. PubMed ID: 19064744
[TBL] [Abstract][Full Text] [Related]
31. Dopamine D2 receptor knockout mice develop features of Parkinson disease.
Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK
Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912
[TBL] [Abstract][Full Text] [Related]
32. The role of autophagy in age-related neurodegeneration.
McCray BA; Taylor JP
Neurosignals; 2008; 16(1):75-84. PubMed ID: 18097162
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
[TBL] [Abstract][Full Text] [Related]
34. Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease.
Bharathi P; Nagabhushan P; Rao KS
Comput Biol Med; 2008 Oct; 38(10):1084-93. PubMed ID: 18823621
[TBL] [Abstract][Full Text] [Related]
35. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
[TBL] [Abstract][Full Text] [Related]
37. Autophagy is involved in the ischemic preconditioning.
Park HK; Chu K; Jung KH; Lee ST; Bahn JJ; Kim M; Lee SK; Roh JK
Neurosci Lett; 2009 Feb; 451(1):16-9. PubMed ID: 19103253
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
Pan T; Kondo S; Zhu W; Xie W; Jankovic J; Le W
Neurobiol Dis; 2008 Oct; 32(1):16-25. PubMed ID: 18640276
[TBL] [Abstract][Full Text] [Related]
39. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia.
Lee HJ; Suk JE; Bae EJ; Lee SJ
Biochem Biophys Res Commun; 2008 Aug; 372(3):423-8. PubMed ID: 18492487
[TBL] [Abstract][Full Text] [Related]
40. Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.
Kao SY
Biochem Biophys Res Commun; 2009 Jul; 385(3):434-8. PubMed ID: 19470380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
